Frank C. Odds

Active 1971–2013

98
Papers
28,963
Citations
87
h-index
98
i10-index

Citations

Citations per year for Frank C. Odds1974: 1 citations1980: 1 citations1981: 3 citations1982: 11 citations1983: 15 citations1984: 20 citations1985: 19 citations1986: 19 citations1987: 30 citations1988: 30 citations1989: 34 citations1990: 45 citations1991: 37 citations1992: 36 citations1993: 60 citations1994: 51 citations1995: 79 citations1996: 64 citations1997: 88 citations1998: 150 citations1999: 175 citations2000: 144 citations2001: 151 citations2002: 171 citations2003: 181 citations2004: 175 citations2005: 186 citations2006: 213 citations2007: 248 citations2008: 261 citations2009: 311 citations2010: 294 citations2011: 335 citations2012: 285 citations2013: 264 citations2014: 275 citations2015: 216 citations2016: 202 citations2017: 212 citations2018: 165 citations2019: 707 citations2020: 691 citations2021: 546 citations2022: 353 citations2023: 238 citations2024: 373 citations2025: 152 citations2026: 1 citations1975–1979: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,208 citing papers, 24% of this breakdownUnited Kingdom: 769 citing papers, 8.3% of this breakdownChina: 545 citing papers, 5.9% of this breakdownGermany: 541 citing papers, 5.9% of this breakdownFrance: 439 citing papers, 4.8% of this breakdownSpain: 366 citing papers, 4% of this breakdownBrazil: 322 citing papers, 3.5% of this breakdownIndia: 297 citing papers, 3.2% of this breakdownNetherlands: 297 citing papers, 3.2% of this breakdownCanada: 295 citing papers, 3.2% of this breakdownItaly: 294 citing papers, 3.2% of this breakdownSwitzerland: 219 citing papers, 2.4% of this breakdown
0%24%Other 28.4%

Fields

  • Medicine73.1%
  • Biochemistry, Genetics and Molecular Biology12.1%
  • Immunology and Microbiology5.1%
  • Agricultural and Biological Sciences4.2%
  • Chemistry1.1%
  • Pharmacology, Toxicology and Pharmaceutics0.8%
  • Other3.6%

Topics

  • Antifungal resistance and susceptibility22.9%
  • Fungal Infections and Studies14.8%
  • Pneumocystis jirovecii pneumonia detection and treatment2.6%
  • Nail Diseases and Treatments2.4%
  • Fungal and yeast genetics research2.3%
  • Plant Pathogens and Fungal Diseases2.2%
  • Other52.8%

Coauthors

All papers

Open in search
  1. Synergy, antagonism, and what the chequerboard puts between them

    Authors: - Journal of Antimicrobial Chemotherapy 2003 cited by 2,452

  2. Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Theoklis E. Zaoutis, John E. Bennett - Clinical Infectious Diseases 2008 cited by 4,909

  3. Antifungal agents: mechanisms of action

    Authors: , , - Trends in Microbiology 2003 cited by 1,185

  4. Contribution of mutations in the cytochrome P450 14α-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans

    Authors: , , , , , , , , , - Microbiology 1999 cited by 377

  5. Immune Recognition ofCandida albicansβ‐glucan by Dectin‐1

    Authors: , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2007 cited by 315

  6. The Mnn2 Mannosyltransferase Family Modulates Mannoprotein Fibril Length, Immune Recognition and Virulence of Candida albicans

    Authors: , , , , , , , , , , - PLoS Pathogens 2013 cited by 122

  7. An insight into the antifungal pipeline: selected new molecules and beyond

    Authors: , , , , - Nature Reviews Drug Discovery 2010 cited by 436

  8. Recognition and Blocking of Innate Immunity Cells by Candida albicans Chitin

    Authors: , , , , , , , , , , , , - Infection and Immunity 2011 cited by 200

  9. Candida orthopsilosis and Candida metapsilosis spp. nov. To Replace Candida parapsilosis Groups II and III

    Authors: , , , , - Journal of Clinical Microbiology 2005 cited by 599

  10. NRG1 represses yeast–hypha morphogenesis and hypha‐specific gene expression in Candida albicans

    Authors: , , , , , , , , , , , , , - The EMBO Journal 2001 cited by 450

  11. Candida albicans Pmr1p, a Secretory Pathway P-type Ca2+/Mn2+-ATPase, Is Required for Glycosylation and Virulence

    Authors: , , , , , , , , - Journal of Biological Chemistry 2005 cited by 201

  12. Outer Chain N-Glycans Are Required for Cell Wall Integrity and Virulence of Candida albicans

    Authors: , , , , , , , , , , - Journal of Biological Chemistry 2005 cited by 234

  13. Glucose Promotes Stress Resistance in the Fungal PathogenCandida albicans

    Authors: , , , , , , - Molecular Biology of the Cell 2009 cited by 190

  14. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences

    Authors: , - The Lancet Infectious Diseases 2002 cited by 782

  15. Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood

    Authors: , , , , , , - Molecular Microbiology 2005 cited by 447

  16. Pathogenesis of Candida infections

    Authors: - Journal of the American Academy of Dermatology 1994 cited by 222

  17. Elevated Cell Wall Chitin in Candida albicans Confers Echinocandin Resistance In Vivo

    Authors: , , , , , , - Antimicrobial Agents and Chemotherapy 2011 cited by 209

  18. Endoplasmic Reticulum α-Glycosidases of Candida albicans Are Required for N Glycosylation, Cell Wall Integrity, and Normal Host-Fungus Interaction

    Authors: , , , , , , , , , , , - Eukaryotic Cell 2007 cited by 150

  19. Fungal morphogenesis and host invasion

    Authors: , , - Current Opinion in Microbiology 2002 cited by 481

  20. Property Differences among the Four Major Candida albicans Strain Clades

    Authors: , , , , , , - Eukaryotic Cell 2009 cited by 164

  21. Candida albicansStrain Maintenance, Replacement, and Microvariation Demonstrated by Multilocus Sequence Typing

    Authors: , , , , , , , , , - Journal of Clinical Microbiology 2006 cited by 142

  22. Melanin Externalization in Candida albicans Depends on Cell Wall Chitin Structures

    Authors: , , , , , , , , - Eukaryotic Cell 2010 cited by 109

  23. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species

    Authors: , - Journal of Clinical Microbiology 1994 cited by 628

  24. Niche-specific regulation of central metabolic pathways in a fungal pathogen

    Authors: , , , , , - Cellular Microbiology 2006 cited by 331